Trials / Completed
CompletedNCT05360992
Pulmonary Embolism: Mechanism and Therapeutic Innovation
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,200 (actual)
- Sponsor
- China National Center for Cardiovascular Diseases · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To explore the pathogenesis, therapy and outcome of pulmonary embolism (PE) and chronic thromboembolic pulmonary hypertension (CTEPH).
Detailed description
The study recruited consecutive outpatients or hospitalized patients diagnosed with pulmonary embolism (PE cohort) and chronic thromboembolic pulmonary hypertension (CTEPH cohort). The follow-up of all patients was performed annually by phone or outpatient visit. The main outcomes were bleeding, recurrent events, and survival. The objective of the study was to explore the pathogenesis, therapy and outcome of PE and CTEPH.
Conditions
Timeline
- Start date
- 2017-01-01
- Primary completion
- 2021-10-13
- Completion
- 2021-10-13
- First posted
- 2022-05-04
- Last updated
- 2022-05-04
Source: ClinicalTrials.gov record NCT05360992. Inclusion in this directory is not an endorsement.